Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
AI Is Reshaping Crypto Faster Than Anyone Expected as AIX Alpha’s New System Signals the Shift
-
Revolution Medicines Announces ASCO Plenary Presentation Highlighting Unprecedented Results from Pivotal Phase 3 RASolute 302 Clinical Trial of Daraxonrasib in Previously Treated Metastatic Pancreatic
-
Immunocore presents updated Phase 1 data of brenetafusp in patients with heavily pretreated advanced melanoma
-
Replimune Presents Final First-in-Human Data for RP2 in Advanced Solid Tumors During Oral Presentation at the 2026 American Society of Clinical Oncology Annual Meeting
-
NeuExcell Therapeutics Announces Encouraging Data of NXL-004 in Recurrent Malignant Glioma at 2026 ASCO
-
Nokia Corporation - Managers' transactions (Hanrahan)
-
Pluvicto™ demonstrated consistent efficacy across key patient subgroups in metastatic hormone-sensitive prostate cancer
-
Solana Unchained Outlines Fixed-Supply Utility Architecture and AI Tool Hub Ahead of Late May Public Allocation Launch
-
Crypto News Today: AlphaPepe Hits $1.38M Raised While Bitcoin Price Prediction Targets $250K
-
National Champions are Honoured at the Closing Ceremony of the Skills Canada National Competition 2026, in Toronto
-
Orion Pharma announces first results from Phase 1/2 TEADES trial with TEAD inhibitor ODM-212 in patients with advanced solid tumours
-
Eikon Therapeutics Presents Data on Clinical-Stage Programs at the 2026 Annual Meeting of the American Society of Clinical Oncology
-
Global Data for BioNTech and Bristol Myers Squibb’s PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial
-
KIAA International LLC Expands Global Leadership with Senior Corporate General Counsel Ms Jagdeep Kaur Joining as Principal Legal Advisor
-
ITM Announces Phase 3 COMPETE Patient-Reported Quality of Life Data with n.c.a. ¹⁷⁷Lu-edotreotide (ITM-11) vs. Everolimus at ASCO 2026
-
Mineralys Therapeutics Presents New Data from the Phase 3 Launch-HTN Trial of Lorundrostat in Participants with Hypertension and Chronic Kidney Disease at European Meeting on Hypertension and Cardiova
-
World Vape Day 2026: One Switch – Everyone Wins
-
ImPact Biotech Presents Updated Data from Phase 1 Trial of Padeliporfin VTP in LA-PDAC and Phase 3 ENLIGHTED Trial in LG-UTUC at ASCO 2026
-
Yanik Guillemette — "Canada Slips Into Recession While Ottawa Bills $200,000 for In-Flight Luxury Meals"
-
Momcozy Launches Plus Baby Wipes Built for Every “Messy Milestone”: 99% Purified Water, 8″ × 8″, Independently Certified by Intertek
-
AI Bots Takes Over XRP Trading as AIX Alpha Launches Its Next‑Gen Automation System
-
Atlanta Based Health Center celebrates 50 Years of Service
-
Cogent Biosciences Announces Detailed Clinical Data from PEAK Phase 3 Trial with Bezuclastinib in Combination with Sunitinib in Gastrointestinal Stromal Tumors (GIST) at 2026 American Society of Clini
-
Replimune Presents 3-Year Landmark Overall Survival Analysis from IGNYTE Clinical Trial During Oral Presentation at the 2026 American Society of Clinical Oncology Annual Meeting
-
Molecular Partners Holds Presentations at ASCO and SNMMI 2026 on DLL3-Targeting Radio-DARPin MP0712, Now Dosing Patients in Phase 1
-
Immatics Presents Clinical Activity of IMA203CD8 PRAME Cell Therapy in Hard-to-Treat Gynecologic Cancers at 2026 ASCO Annual Meeting
-
Taklimakan Rally 2026: GWM TANK Dominates the Unforgiving Desert
-
12B SPORTS Named Main Sponsor of VR46 Racing Team for the 2026 MotoGP Season
-
Havila Shipping ASA: Ruling in favor of the company in the arrest case in Borgarting Court of Appeal
-
Mikey Moran Launches GLZD, Combining Skincare and Fragrance Into Men’s Grooming Routine
-
National Nursing Organizations File Nurse-Forward Lawsuit Against the Department of Education Over Professional Degree Designation
-
Fobi AI Provides Corporate Update Regarding FFCTO Revocation Process and Q3 Interim Filings
-
Enabled Talent Hosts Cross-Party MPP Breakfast Reception at Queen’s Park During National AccessAbility Week
-
Crypto News Today: AlphaPepe Presale Stage 17 Nears Sell Out While XRP Price Prediction Eyes $7.00
-
Monument’s Drill Assay Results Highlight Selinsing Gold Mine Expansion Potential
-
New Earth Resources Announces Private Placement
-
Canadian Large Cap Leaders Split Corp. Establishes At-The-Market Equity Program
-
FCHL Receives Nasdaq Deficiency Notice on May 26, 2026
-
Atlantic Petroleum – Condensed Consolidated Interim Report – 1st Quarter 2026
-
National Nursing Organizations File Nurse-Forward Lawsuit Against the Department of Education Over Professional Degree Designation
-
Fulginiti Law Recovers $1.6 Million for Motor Vehicle Accident Client
-
Clean Energy Technologies Receives Notice of Deficiency from Nasdaq
-
ThreeD Capital Inc. Releases Results For the Three and Nine Months Ended March 31, 2026
-
K92 Mining Announces Voting Results of Annual General Meeting of Shareholders
-
Cash and Gift Cards Dominate Consumer Reward Preferences: Kashkick Survey of 224,000+ Aligns With $507B U.S. Gift Card Market
-
Renown Jazz Artists Hit the Stage to Help Georgians Receive Healthcare
-
Vitalist Announces Change of Auditor
-
Celularity Receives Nasdaq Notice Regarding Form 10-Q
-
A New Chapter Is Emerging in Pakistan-China Relations
-
Fairfax Completes Sale of Portion of its Interest in Poseidon Corp.
